This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Buckwalter JA, Martin JA: Osteoarthritis. Adv Drug Deliv Rev 2006; 58: 150–167.BuckwalterJAMartinJA:Osteoarthritis.Adv Drug Deliv Rev2006;58:150–167.10.1016/j.addr.2006.01.00616530881Search in Google Scholar
Cochran L, Banerjee P: Baby boomers and seniors: Understanding their leisure values enhances programs. Activ Adapt Aging 2010; 34: 196–215.CochranLBanerjeeP:Baby boomers and seniors: Understanding their leisure values enhances programs.Activ Adapt Aging2010;34:196–215.10.1080/01924788.2010.501484Search in Google Scholar
Bhatia D, Bejarano T, Novo M: Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci 2013; 5: 30–38.BhatiaDBejaranoTNovoM:Current interventions in the management of knee osteoarthritis.J Pharm Bioallied Sci2013;5:30–38.10.4103/0975-7406.106561361233623559821Search in Google Scholar
Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM et al.: Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol 2016; 12: 580–592.RobinsonWHLepusCMWangQRaghuHMaoRLindstromTM:Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.Nat Rev Rheumatol2016;12:580–592.10.1038/nrrheum.2016.136550021527539668Search in Google Scholar
Persson MSM, Sarmanova A, Doherty M, Zhang W: Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: A meta-analysis of randomized controlled trials. Rheumatology 2018; 57: 1830–1837.PerssonMSMSarmanovaADohertyMZhangW:Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: A meta-analysis of randomized controlled trials.Rheumatology2018;57:1830–1837.10.1093/rheumatology/key131619941729917100Search in Google Scholar
Ali M, Oderuth E, Atchia I, Malviya A: The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: A systematic literature review. J Hip Preserv Surg 2018; 5: 209–219.AliMOderuthEAtchiaIMalviyaA:The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: A systematic literature review.J Hip Preserv Surg2018;5:209–219.10.1093/jhps/hny027620670230393547Search in Google Scholar
Meheux CJ, McCulloch PC, Lintner DM, Varner KE, Harris JD: Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: A systematic review. Arthroscopy 2016; 32: 495–505.MeheuxCJMcCullochPCLintnerDMVarnerKEHarrisJD:Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: A systematic review.Arthroscopy2016;32:495–505.10.1016/j.arthro.2015.08.00526432430Search in Google Scholar
Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA et al.: Efficacy of platelet-rich plasma for chronic tennis elbow: A double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med 2014; 42: 463–471.MishraAKSkrepnikNVEdwardsSGJonesGLSampsonSVermillionDA:Efficacy of platelet-rich plasma for chronic tennis elbow: A double-blind, prospective, multicenter, randomized controlled trial of 230 patients.Am J Sports Med2014;42:463–471.10.1177/036354651349435923825183Search in Google Scholar
Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M: Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 2012; 40: 534–541.Mei-DanOCarmontMRLaverLMannGMaffulliNNyskaM:Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus.Am J Sports Med2012;40:534–541.10.1177/036354651143123822253252Search in Google Scholar
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA: Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009; 37: 2259–2272.FosterTEPuskasBLMandelbaumBRGerhardtMBRodeoSA:Platelet-rich plasma: from basic science to clinical applications.Am J Sports Med2009;37:2259–2272.10.1177/036354650934992119875361Search in Google Scholar
Lee JW, Kwon OH, Kim TK, Cho YK, Choi KY, Chung HY et al.: Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg 2013; 40: 530–535.LeeJWKwonOHKimTKChoYKChoiKYChungHY:Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups.Arch Plast Surg2013;40:530–535.10.5999/aps.2013.40.5.530Search in Google Scholar
Kakudo N, Morimoto N, Kushida S, Ogawa T, Kusumoto K: Plateletrich plasma releasate promotes angiogenesis in vitro and in vivo. Med Mol Morphol 2014; 47: 83–89.KakudoNMorimotoNKushidaSOgawaTKusumotoK:Plateletrich plasma releasate promotes angiogenesis in vitro and in vivo.Med Mol Morphol2014;47:83–89.10.1007/s00795-013-0045-9Search in Google Scholar
Kajikawa Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A et al.: Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol 2008; 215: 837–845.KajikawaYMoriharaTSakamotoHMatsudaKOshimaYYoshidaA:Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing.J Cell Physiol2008;215:837–845.10.1002/jcp.21368Search in Google Scholar
Yin W, Qi X, Zhang Y, Sheng J, Xu Z, Tao S et al.: Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects. J Transl Med 2016; 14: 73.YinWQiXZhangYShengJXuZTaoS:Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects.J Transl Med2016;14:73.10.1186/s12967-016-0825-9Search in Google Scholar
Moher D, Liberati A, Altman DG; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336–341.MoherDLiberatiAAltmanDG;PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Int J Surg2010;8:336–341.10.1016/j.ijsu.2010.02.007Search in Google Scholar
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al.: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials 1996; 17: 1–12.JadadARMooreRACarrollDJenkinsonCReynoldsDJGavaghanDJ:Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials1996;17:1–12.10.1016/0197-2456(95)00134-4Search in Google Scholar
Di Sante L, Villani C, Santilli V, Valeo M, Bologna E, Imparato L et al.: Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis. Med Ultrason 2016; 18: 463–468.Di SanteLVillaniCSantilliVValeoMBolognaEImparatoL:Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis.Med Ultrason2016;18:463–468.10.11152/mu-87427981279Search in Google Scholar
Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P et al.: Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: A randomized controlled study. Am J Sports Med 2016; 44: 664–671.DallariDStagniCRaniNSabbioniGPelottiPTorricelliP:Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: A randomized controlled study.Am J Sports Med2016;44:664–671.10.1177/036354651562038326797697Search in Google Scholar
Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R et al.: Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics 2013; 36: e1501–e1508.BattagliaMGuaraldiFVanniniFRossiGTimonciniABudaR:Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis.Orthopedics2013;36:e1501–e1508.10.3928/01477447-20131120-1324579221Search in Google Scholar
Pereira D, Peleteiro B, Araújo J, Branco J, Santos RA, Ramos E: The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 2011; 19: 1270–1285.PereiraDPeleteiroBAraújoJBrancoJSantosRARamosE:The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review.Osteoarthritis Cartilage2011;19:1270–1285.10.1016/j.joca.2011.08.00921907813Search in Google Scholar
Li G, Yin J, Gao J, Cheng TS, Pavlos NJ, Zhang C et al.: Subchondral bone in osteoarthritis: Insight into risk factors and microstructural changes. Arthritis Res Ther 2013; 15: 223.LiGYinJGaoJChengTSPavlosNJZhangC:Subchondral bone in osteoarthritis: Insight into risk factors and microstructural changes.Arthritis Res Ther2013;15:223.10.1186/ar4405406172124321104Search in Google Scholar
Mlynarek RA, Kuhn AW, Bedi A: Platelet-rich plasma (PRP) in orthopedic sports medicine. Am J Orthop (Belle Mead NJ) 2016; 45: 290–326.MlynarekRAKuhnAWBediA:Platelet-rich plasma (PRP) in orthopedic sports medicine.Am J Orthop (Belle Mead NJ)2016;45:290–326.Search in Google Scholar